Education
About Us
Working with TipRanks
Follow Us
InMed Pharmaceuticals (INM)
NASDAQ:INM
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 6.29M | $ 5.48M | $ 1.40M | $ 0.00 | $ 0.00 |
| Gross Profit | $ 1.51M | $ 1.86M | $ 699.85K | $ -197.03K | $ -183.09K |
| Operating Income | $ -11.12M | $ -11.10M | $ -17.76M | $ -9.92M | - |
| EBITDA | $ -10.30M | $ -10.31M | $ -17.10M | $ -9.80M | - |
| Net Income | $ -10.50M | $ -10.53M | $ -23.95M | $ -10.20M | $ -8.94M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.61M | $ 8.91M | $ 6.22M | $ 7.41M | $ 5.84M |
| Total Assets | $ 11.82M | $ 14.11M | $ 12.79M | $ 9.78M | $ 7.50M |
| Total Debt | $ 962.66K | $ 391.71K | $ 793.77K | $ 269.77K | $ 316.28K |
| Net Debt | $ -5.61M | $ -8.52M | $ -5.38M | $ -7.09M | $ -5.48M |
| Total Liabilities | $ 2.62M | $ 2.02M | $ 3.71M | $ 2.40M | $ 1.92M |
| Stockholders' Equity | $ 9.21M | $ 12.09M | $ 9.08M | $ 7.38M | $ 5.58M |
| Cash Flow | |||||
| Free Cash Flow | $ -7.00M | $ -7.45M | $ -15.62M | $ -9.79M | - |
| Operating Cash Flow | $ -6.99M | $ -7.28M | $ -15.58M | $ -9.79M | - |
| Investing Cash Flow | $ -9.29K | $ -661.80K | $ -673.00K | $ -1.73K | $ 3.62M |
| Financing Cash Flow | $ 4.65M | $ 10.68M | $ 15.07M | $ 10.85M | - |